Zydus Cadila

Thursday, Apr 25, 2024 | Last Update : 02:28 PM IST

Zydus Cadila starts supply of COVID-19 vaccine to govt

ZyCoV-D is a three-dose vaccine administered intradermally

02 Feb 2022 10:42 AM

A health workers hold a vial of Zydus Cadila's ZyCov-D Covid vaccine. (Photo: zyduscadila.com)

Centre places purchase order for Zydus Cadila's needle-free Covid vaccine

ZyCoV-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

07 Nov 2021 1:24 PM

ZyCov-D is world's first indigenously developed DNA-based needle-free COVID-19 vaccine. (Photo: www.zyduscadila.com)

Zydus Cadila to reduce its Covid vaccine price to Rs 265 a dose, final decision soon

The company's Covid vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20

31 Oct 2021 2:50 PM

he Covishield, Covaxin and Sputnik V vaccines are being given to only those above 18 years of age and unlike ZyCoV-D, which is a three-dose vaccine, these are administered in two doses. (Photo:Zyduscadila)

ZyCoV-D to be introduced in Covid vaccination drive shortly: Govt

ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)

30 Sep 2021 7:34 PM

Zydus Cadila's COVID-19 vaccine ZyCoV-D. (Photo: Zyduscadila/File)

Zydus Cadila to seek approval for two-dose regimen of its approved three-dose vaccine

The trials for the two-dose regimen are underway

12 Sep 2021 2:01 PM

Zydus Cadila's COVID-19 vaccine ZyCoV-D. (Photo:Zyduscadila)

More clarity on ZyCOV-D vaccine price by next week, says Zydus Group MD Sharvil Patel

Zydus Cadila announced that once they get clearance then they are expected to supply 5 crores doses per month till December 21

21 Aug 2021 5:45 PM

A health worker holds one vial of Zydus Cadila's ZyCoV-D vaccine. (Photo: AP)

Centre says Zydus Cadila's vaccines for children may be available in near future

Zydus Cadila has concluded its trial for children between the age group of 12 to 18

16 Jul 2021 1:37 PM

Emergency approval for Zydus Cadila to take few more days, say sources

ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body

12 Jul 2021 1:01 PM

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Seven Indian pharma players race to develop COVID-19 vaccine. (Representative Image)

Seven Indian pharma players race to develop vaccine for deadly coronavirus

Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end

19 Jul 2020 4:08 PM

India’s Zydus Cadila plans to complete late-stage trials for its novel coronavirus vaccine candidate by February or March 2021. (AP Photo)

Zydus Cadila to end COVID-19 vaccine trial in 2021

Cadila’s vaccine candidate, known as ZyCov-D, is one of dozens being developed around the world to fight the coronavirus pandemic

17 Jul 2020 3:24 PM

Tofacitinib will be manufactured at the Zydus Cadila's formulations manufacturing facility at Moraiya, Ahmedabad.

Zydus receives tentative approval from USFDA for Tofacitinib tablets

Tofacitinib is used to treat moderate to severe forms of rheumatoid arthritis, company said in a BSE filing.

06 Apr 2019 5:04 PM

Zydus Cadila to launch seasonal flu vaccine

Company said vaccine provides protection from four influenza viruses — H1N1, H3N2, Type B or Brisbane and Type B.

24 Feb 2017 2:42 PM

1 of 1

Columns

Dilip Cherian

zydus cadila